Beta Drugs Limited (NSE:BETA)

Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	13,348	19,235	11,861	6,027	5,437	1,038
Market Cap Growth	-30.83%	62.17%	96.79%	10.87%	423.79%	200.00%
Enterprise Value	13,580	19,147	11,782	6,023	5,446	1,127
Last Close Price	1322.30	1905.50	1175.00	597.10	538.57	114.29
PE Ratio	33.44	45.35	32.55	19.62	21.90	8.85
PS Ratio	3.47	5.31	4.01	2.65	2.96	0.89
PB Ratio	6.04	9.76	7.55	4.91	5.89	1.51
P/TBV Ratio	6.30	10.20	7.82	5.10	6.17	1.59
P/FCF Ratio	-	-	61.41	116.57	53.30	8.08
P/OCF Ratio	-	53.22	38.35	25.78	18.35	5.58
EV/Sales Ratio	3.53	5.28	3.98	2.65	2.96	0.97
EV/EBITDA Ratio	18.31	26.06	19.67	11.27	12.75	4.55
EV/EBIT Ratio	22.85	30.84	23.50	14.00	15.37	6.29
EV/FCF Ratio	-	-	61.00	116.49	53.39	8.77
Debt / Equity Ratio	0.66	0.70	0.09	0.17	0.22	0.26
Debt / EBITDA Ratio	1.96	1.88	0.25	0.38	0.48	0.70
Debt / FCF Ratio	-	-	0.76	3.93	2.02	1.36
Net Debt / Equity Ratio	0.11	-0.05	-0.09	0.01	0.04	0.10
Net Debt / EBITDA Ratio	0.31	-0.12	-0.23	0.02	0.08	0.28
Net Debt / FCF Ratio	-	12.56	-0.72	0.23	0.32	0.55
Asset Turnover	-	1.05	1.31	1.27	1.34	1.03
Inventory Turnover	-	3.88	4.51	4.88	5.83	5.09
Quick Ratio	-	2.54	1.42	1.43	1.42	1.45
Current Ratio	-	3.22	2.10	2.03	1.98	2.04
Return on Equity (ROE)	-	23.95%	26.03%	28.54%	30.85%	18.65%
Return on Assets (ROA)	-	11.24%	13.85%	15.10%	16.09%	9.97%
Return on Invested Capital (ROIC)	18.41%	27.91%	28.04%	29.31%	29.96%	17.56%
Return on Capital Employed (ROCE)	-	18.60%	29.60%	31.80%	32.60%	21.30%
Earnings Yield	3.11%	2.21%	3.07%	5.10%	4.57%	11.30%
FCF Yield	-	-0.04%	1.63%	0.86%	1.88%	12.38%
Buyback Yield / Dilution	-10.48%	-5.00%	4.76%	-	-	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.